Experimental Nuromodulation

We study different (mainly) minimal-invasive and non-invasive methods of neuromodulation, including transcranial electrical stimulation (TES), transcranial magnetic stimulation (TMS), and transcutaneous vagus nerve stimulation (tVNS).

Transcranial electrical stimulation (TES) 

Transcranial electrical stimulation (TES) applies weak constant currents (transcranial direct current stimulation, tDCS), constantly alternating currents (transcranial alternating current stimulation, tACS), or currents oscillating at random frequencies (transcranial random noise stimulation, tRNS) through cortical electrodes to achieve neuromodulation

 

Systematic Reviews/Meta-Analysis on the Topic:

Transcranial magnetic stimulation (TMS)

Transcranial magnetic stimulation (TMS) excites or inhibits brain areas, by inducing a magnetic field with electrical currents through a magnetic coil. There are specific forms or repetetive TMS (rTMS) that apply patterns of pulse (e.g. Theta-burst stimulation (TBS)).

 

Systematic Reviews/Meta-Analysis:

  • Sigrist C, Vöckel J, MacMaster FP, Farzan F, Croarkin PE, Galletly C, Kaess M, Bender S, Koenig J. Transcranial magnetic stimulation in the treatment of adolescent depression –A systematic review and meta-analysis of aggregated and individual patient data from uncontrolled studies. European Child & Adolescent Psychiatry, 2022; 31(1): 1501-1525, 5.349 Impact; DOI: 10.1007/s00787-022-02021-7 [PubMed]

 

Transcutaneous vagus nerve stimulation (tVNS)

Transcutaneous vagus nerve stimulation (tVNS) aims to modulate vagal activity. Our lab is leading in the development of transcutaneous auricular vagus nerve stimulation (taVNS) for children and adolescents with psychiatric disorders.

We have led international efforts to formulate Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation. We are working towards standardized clinical protocols in the treatment of pediatric patients. Further, we are interested in the validation of different biomarkers of taVNS, including heart rate variability, salivary alpha amylase, or cortex oxygenation

We are part of the European Research Network on tVNS, funded by the Research Foundation – Flanders (FWO) via the Scientific Research Networks Grant. 

 

Selected Empirical Paper:

  • Koenig J, Parzer P, Haigis N, Liebemann J, Jung T, Resch F, Kaess M. Effects of Acute Transcutaneous Vagus Nerve Stimulation on Emotion Recognition in Adolescent Depression. Psychological Medicine2021: 51(3):511-520; DOI: 10.1017/S00332917190034905.641 Impact Factor [PubMed]
  • Höper S, Kaess M, Koenig J. Prefrontal Cortex Oxygenation and Autonomic Nervous System Activity under Transcutaneous Auricular Vagus Nerve Stimulation in Adolescents. Autonomic Neuroscience, 2022 ;241:103008, 2.355 Impact Factor; DOI: 10.1016/j.autneu.2022.103008  [PubMed]

Systematic Reviews/Meta-Analysis:

  • Sigrist C, Torki B, Bolz L, Jeglorz T, Bolz A, Koenig J. Transcutaneous Auricular Vagus Nerve Stimulation in Pediatric Patients – A Systematic Review of Clinical Treatment Protocols and Stimulation Parameters. Neuromodulation, in press, 4.722 Impact Factor; DOI: 10.1016/j.neurom.2022.07.007 [PubMed]
  • Wolf V, Kühnel A, Teckentruo V, Koenig J, Kroemer NB. Does non-invasive vagus nerve stimulation affect heart rate variability? A living and interactive Bayesian meta-analysis. Psychophysiology, 2021;58(11):e139333.378 Impact Factor [PubMed]
  • Giraudier M, VenturaBort, C, Burger AM, Claes N, D’Agostini M, Fischer R, Franssen M, Kaess M, Koenig J, Liepelt R, Nieuwenhuis S, Sommer A, Usischenko T, Van Diest I, von Leupoldt A, Warren C, Weymar M. Evidence for a modulating effect of transcutaneous auricular vagus nerve stimulation on salivary alpha-amylase as indirect noradrenergic marker: a pooled mega-analysis. Brain Stimulation, 2022; 15(6):1378-1388, 9.184 Impact Factor; DOI: 10.1016/j.brs.2022.09.009 [PubMed]
  • tVNS Consensus Group - Farmer AD, Strzelczyk A, Finisguerra A, Gourine AV, Gharabaghi A, Hasan A, Burger A, Jaramillo AM, Mertens A, Majid A, Verkuil B, Badran BW, Ventura-Bort C, Gaul C, Beste C, Warren CM, Quintana D, Hämmerer D, Freri E, Frangos E, Tobaldini E, Kaniusas E, Rosenow F, Capone F, Panetsos F, Ackland G, Kaithwas G, O’Leary GH, Genheimer H, Jacobs H, Van Diest I, Schoenen J, Redgrave J, Fang J, Deuchars J, Széles JC, Thayer JF, More K, Vonck K, Steenbergen L, Vianna L, McTeague LM, Ludwig M, Veldhuizen MG, De Couck M, Casazza M, Keute M, Bikson M, Andreatta M, D’Agostini M, Weymar M, Betts M, Prigge M, Kaess M, Roden M, Thai M, Schuster NM, Montano N, Hansen N, Kroemer NB, Rong P, Fischer R, Howland RH, Sclocco R, Sellaro R, Garcia RG, Bauer S, Gancheva S, Stavrakis S, Kampusch S, Deuchars SA, Wehner S, Laborde S, Usichenko T, Polak T, Zähle T, Borges U, Teckentrup V, Jandackova VK, Napadow V, Koenig J. International Consensus Based Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020). Frontiers in Human Neuroscience, Brain Imaging and Stimulation, 2021; 14:568051; DOI: 10.3389/fnhum.2020.568051; 2.673 Impact Factor [PubMed]

last update 2023 10 08

Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen

Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.